{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:00:53Z","timestamp":1793368853317,"version":"4.5.0"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,2,6]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To understand the distribution characteristics and clinical significance of cerebrospinal fluid (CSF) oligoclonal bands (OCBs) in different nervous system diseases besides typical central nervous system (CNS) inflammatory demyelinating disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Material<\/jats:title>\n                  <jats:p>A total of 2259 patients who underwent CSF examination for OCBs at Peking University First Hospital from January 2011 to December 2023 were tested. A cohort of 257 patients presenting with various types of OCBs but without CNS inflammatory demyelinating diseases was included in the analysis. Relevant medical history was collected from all patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>OCBs were most common in patients with autoimmune encephalitis. OCB types II and III were most common in patients with autoimmune encephalitis and CNS infection, whereas OCB types IV and V were present in immune-mediated neuropathy mostly. The distribution of OCBs also varied among different disease subtypes. Other CSF characteristics varied between diseases with different OCBs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In addition to CNS inflammatory demyelinating diseases, OCBs also appear in other neurological diseases including cerebral angiopathy and neurodegenerative conditions, informing the potential immune background. Further research is still needed to determine the significance of OCBs in these diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2024-000912","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T01:20:25Z","timestamp":1740532825000},"page":"e000912","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["CSF oligoclonal bands in neurological diseases besides CNS inflammatory demyelinating disorders"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-3156","authenticated-orcid":false,"given":"Jingru","family":"Ren","sequence":"first","affiliation":[{"name":"Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4266-0818","authenticated-orcid":false,"given":"Jianchun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0819-4543","authenticated-orcid":false,"given":"Ran","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5346-9549","authenticated-orcid":false,"given":"Jing","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6177-9570","authenticated-orcid":false,"given":"Yan","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-9090","authenticated-orcid":false,"given":"Hongjun","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-3060","authenticated-orcid":false,"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"2025072812124614000_7.1.e000912.1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.6.865"},{"key":"2025072812124614000_7.1.e000912.2","first-page":"2465","article-title":"Establishment and consistency verification of the standard operation procedure for laboratory detection of immunoglobulin G oligoclonal bands in cerebrospinal fluid","volume":"101","author":"Xiaoni","year":"2021","journal-title":"Natl Med J China (Peking)"},{"key":"2025072812124614000_7.1.e000912.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.8.897"},{"key":"2025072812124614000_7.1.e000912.4","doi-asserted-by":"publisher","DOI":"10.3109\/00365517709091498"},{"key":"2025072812124614000_7.1.e000912.5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/147323001204000427","article-title":"Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability","volume":"40","author":"Tomizawa","year":"2012","journal-title":"J Int Med Res"},{"key":"2025072812124614000_7.1.e000912.6","doi-asserted-by":"publisher","DOI":"10.1002\/jdn.10121"},{"key":"2025072812124614000_7.1.e000912.7","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2022.2039591"},{"key":"2025072812124614000_7.1.e000912.8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.47936\/encephalitis.2020.00038","article-title":"Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study","volume":"1","author":"Hong","year":"2021","journal-title":"Encephalitis"},{"key":"2025072812124614000_7.1.e000912.9","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-011-0237-4"},{"key":"2025072812124614000_7.1.e000912.10","first-page":"301","article-title":"Peripheral neuropathy and anti-MAG antibodies","volume":"3","author":"Latov","year":"1988","journal-title":"Crit Rev Neurobiol"},{"key":"2025072812124614000_7.1.e000912.11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1440-1789.2000.00309.x","article-title":"Crow\u2013Fukase syndrome","volume":"20","author":"Koike","year":"2000","journal-title":"Neuropathology"},{"key":"2025072812124614000_7.1.e000912.12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/01.CON.0000455879.99050.26","article-title":"Paraproteinemic Neuropathies","volume":"20","author":"Mauermann","year":"2014","journal-title":"Continuum (Minneap Minn)"},{"key":"2025072812124614000_7.1.e000912.13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-3-323"},{"key":"2025072812124614000_7.1.e000912.14","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqv088"},{"key":"2025072812124614000_7.1.e000912.15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/diagnostics11010037","article-title":"Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases","volume":"11","author":"Pannewitz-Makaj","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2025072812124614000_7.1.e000912.16","doi-asserted-by":"crossref","first-page":"1170360","DOI":"10.3389\/fneur.2023.1170360","article-title":"CSF oligoclonal IgG bands are not associated with ALS progression and prognosis","volume":"14","author":"Klose","year":"2023","journal-title":"Front Neurol"},{"key":"2025072812124614000_7.1.e000912.17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1212\/WNL.31.5.590","article-title":"Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease","volume":"31","author":"Rostr\u00f6m","year":"1981","journal-title":"Neurology (ECronicon)"},{"key":"2025072812124614000_7.1.e000912.18","doi-asserted-by":"publisher","DOI":"10.1177\/135245859800400304"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2024-000912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T19:12:57Z","timestamp":1753729977000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2024-000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjno-2024-000912"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2024-000912","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}